id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-E-1226-0007,FDA,FDA-2025-E-1226,Determination of Regulatory Review Period for Purposes of Patent Extension; AEROPACE,Notice,Determinations,2026-02-26T05:00:00Z,2026,2,2026-02-26T05:00:00Z,2026-04-28T03:59:59Z,2026-02-26T20:32:36Z,2026-03849,1,0,09000064b91dec81
FDA-2025-E-1226-0006,FDA,FDA-2025-E-1226,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-12-03T05:00:00Z,2025,12,2025-12-03T05:00:00Z,,2025-12-03T17:23:58Z,,0,0,09000064b90aad99
FDA-2025-E-1226-0005,FDA,FDA-2025-E-1226,Letter from U. S. Patent and Trademark Office,Other,Letter(s),2025-10-20T04:00:00Z,2025,10,2025-10-20T04:00:00Z,,2025-10-20T20:08:34Z,,0,0,09000064b9035b59
FDA-2025-E-1226-0004,FDA,FDA-2025-E-1226,Letter to U.S. Patent and Trademark Office,Other,Letter(s),2025-06-16T04:00:00Z,2025,6,2025-06-16T04:00:00Z,,2025-06-16T19:17:11Z,,0,0,09000064b8e11f1a
FDA-2025-E-1226-0001,FDA,FDA-2025-E-1226,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-05-14T04:00:00Z,2025,5,2025-05-14T04:00:00Z,,2025-05-21T22:12:27Z,,0,0,09000064b8d47ab6
FDA-2025-E-1226-0002,FDA,FDA-2025-E-1226,"Patent Extension Application from Bookoff McAndrews, PLLC (on behalf of Lungpacer Medical, Inc.)",Other,Application,2025-05-14T04:00:00Z,2025,5,2025-05-14T04:00:00Z,,2025-05-21T22:12:27Z,,0,0,09000064b8d47ab7
FDA-2025-E-1226-0003,FDA,FDA-2025-E-1226,Requirement for Information,Other,Letter(s),2025-05-14T04:00:00Z,2025,5,2025-05-14T04:00:00Z,,2025-05-21T22:12:27Z,,0,0,09000064b8d4842d